purchase customization

1 Study Coverage
1.1 Prescription Dermatological Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Market by Application
1.3.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Dermatological Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Dermatological Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Dermatological Drugs Sales by Region
2.4.1 Global Prescription Dermatological Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Dermatological Drugs by Region (2023-2028)
2.5 Global Prescription Dermatological Drugs Revenue by Region
2.5.1 Global Prescription Dermatological Drugs Revenue by Region (2017-2022)
2.5.2 Global Prescription Dermatological Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Dermatological Drugs Sales by Manufacturers
3.1.1 Global Top Prescription Dermatological Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Dermatological Drugs in 2021
3.2 Global Prescription Dermatological Drugs Revenue by Manufacturers
3.2.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2021
3.3 Global Prescription Dermatological Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Dermatological Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Dermatological Drugs Sales by Type
4.1.1 Global Prescription Dermatological Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Dermatological Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
4.2 Global Prescription Dermatological Drugs Revenue by Type
4.2.1 Global Prescription Dermatological Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Dermatological Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Dermatological Drugs Price by Type
4.3.1 Global Prescription Dermatological Drugs Price by Type (2017-2022)
4.3.2 Global Prescription Dermatological Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prescription Dermatological Drugs Sales by Application
5.1.1 Global Prescription Dermatological Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Prescription Dermatological Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
5.2 Global Prescription Dermatological Drugs Revenue by Application
5.2.1 Global Prescription Dermatological Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Prescription Dermatological Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Prescription Dermatological Drugs Price by Application
5.3.1 Global Prescription Dermatological Drugs Price by Application (2017-2022)
5.3.2 Global Prescription Dermatological Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Dermatological Drugs Market Size by Type
6.1.1 North America Prescription Dermatological Drugs Sales by Type (2017-2028)
6.1.2 North America Prescription Dermatological Drugs Revenue by Type (2017-2028)
6.2 North America Prescription Dermatological Drugs Market Size by Application
6.2.1 North America Prescription Dermatological Drugs Sales by Application (2017-2028)
6.2.2 North America Prescription Dermatological Drugs Revenue by Application (2017-2028)
6.3 North America Prescription Dermatological Drugs Market Size by Country
6.3.1 North America Prescription Dermatological Drugs Sales by Country (2017-2028)
6.3.2 North America Prescription Dermatological Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prescription Dermatological Drugs Market Size by Type
7.1.1 Europe Prescription Dermatological Drugs Sales by Type (2017-2028)
7.1.2 Europe Prescription Dermatological Drugs Revenue by Type (2017-2028)
7.2 Europe Prescription Dermatological Drugs Market Size by Application
7.2.1 Europe Prescription Dermatological Drugs Sales by Application (2017-2028)
7.2.2 Europe Prescription Dermatological Drugs Revenue by Application (2017-2028)
7.3 Europe Prescription Dermatological Drugs Market Size by Country
7.3.1 Europe Prescription Dermatological Drugs Sales by Country (2017-2028)
7.3.2 Europe Prescription Dermatological Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Dermatological Drugs Market Size by Type
8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Dermatological Drugs Market Size by Application
8.2.1 Asia Pacific Prescription Dermatological Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Prescription Dermatological Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Prescription Dermatological Drugs Market Size by Region
8.3.1 Asia Pacific Prescription Dermatological Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Prescription Dermatological Drugs Market Size by Type
9.1.1 Latin America Prescription Dermatological Drugs Sales by Type (2017-2028)
9.1.2 Latin America Prescription Dermatological Drugs Revenue by Type (2017-2028)
9.2 Latin America Prescription Dermatological Drugs Market Size by Application
9.2.1 Latin America Prescription Dermatological Drugs Sales by Application (2017-2028)
9.2.2 Latin America Prescription Dermatological Drugs Revenue by Application (2017-2028)
9.3 Latin America Prescription Dermatological Drugs Market Size by Country
9.3.1 Latin America Prescription Dermatological Drugs Sales by Country (2017-2028)
9.3.2 Latin America Prescription Dermatological Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Dermatological Drugs Market Size by Type
10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Dermatological Drugs Market Size by Application
10.2.1 Middle East and Africa Prescription Dermatological Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Prescription Dermatological Drugs Market Size by Country
10.3.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 LEO Pharma
11.3.1 LEO Pharma Corporation Information
11.3.2 LEO Pharma Overview
11.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 LEO Pharma Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 LEO Pharma Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Overview
11.7.3 Allergan Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bausch Health Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bausch Health Recent Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Overview
11.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PharmaDerm Pharmaceuticals Recent Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Overview
11.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Allergan Inamed Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Dermatological Drugs Industry Chain Analysis
12.2 Prescription Dermatological Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Dermatological Drugs Production Mode & Process
12.4 Prescription Dermatological Drugs Sales and Marketing
12.4.1 Prescription Dermatological Drugs Sales Channels
12.4.2 Prescription Dermatological Drugs Distributors
12.5 Prescription Dermatological Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Dermatological Drugs Industry Trends
13.2 Prescription Dermatological Drugs Market Drivers
13.3 Prescription Dermatological Drugs Market Challenges
13.4 Prescription Dermatological Drugs Market Restraints
14 Key Findings in The Global Prescription Dermatological Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer